Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease

被引:16
|
作者
Khera, Angela J.
Chase, Janet W.
Salzberg, Michael
Thompson, Alexander J. V.
Kamm, Michael A.
机构
[1] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
关键词
inflammatory bowel disease; constipation; fecal incontinence; behavioral treatment; biofeedback; QUALITY-OF-LIFE; RANDOMIZED-CONTROLLED-TRIAL; FUNCTIONAL GASTROINTESTINAL DISORDERS; LONG-TERM EFFICACY; IBS-LIKE SYMPTOMS; BIOFEEDBACK THERAPY; DYSSYNERGIC DEFECATION; CLINICAL-ASSESSMENT; SHOWS BIOFEEDBACK; GLOBAL IMPRESSION;
D O I
10.1093/ibd/izy344
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Patients with inflammatory bowel disease (IBD) often experience functional bowel symptoms despite achieving disease remission. Although behavioral treatment (bowel and pelvic floor muscle retraining) is effective for managing constipation or fecal incontinence in non-IBD patients, there is limited evidence for its efficacy in patients with quiescent inflammatory bowel disease. The aim of this study was to evaluate the outcome of gut-directed behavioral treatment, including pelvic floor muscle training, for symptoms of constipation or fecal incontinence in patients with IBD in disease remission. Methods The outcome of consecutive patients with IBD in remission and symptoms of constipation or fecal incontinence was evaluated. Patients referred to a multidisciplinary gastroenterology clinic underwent gut-directed behavioral treatment, including pelvic floor muscle training. The primary outcome was patient-reported rating of change in symptoms on a 7-point Likert scale at the completion of treatment. Results Forty IBD patients (median age, 35 years; 80% female; 24 Crohn's disease [CD], 12 ulcerative colitis [UC], 4 UC with ileoanal pouch) with ongoing symptoms of constipation (55%) or fecal incontinence (45%), despite drug therapy, were included. The median symptom duration at referral was 2 years. Thirty-five (87%) completed treatment with a median of 2 sessions. Improvement of 6 = much better or 7 = very much better was reported by 77% (17/22) with fecal incontinence and 83% (15/18) with constipation. Improvement occurred irrespective of IBD diagnosis, previous perianal fistulae, colorectal surgery, presence of an ileoanal pouch, or past obstetric trauma. Conclusions Behavioral treatment effectively improves functional gut symptoms in a large majority of patients who are in IBD disease remission and who have not responded to drug therapy.
引用
收藏
页码:620 / 626
页数:7
相关论文
共 50 条
  • [41] Treatment of constipation and fecal incontinence in stroke patients - Randomized controlled trial
    Harari, D
    Norton, C
    Lockwood, L
    Swift, C
    STROKE, 2004, 35 (11) : 2549 - 2555
  • [42] Nurse- and Pelvic Floor Physical Therapist-Led Bowel Training in Patients With Fecal Incontinence in a Tertiary Care Center
    Visscher, Arjan P.
    Leemeijer, Anna
    Felt-Bersma, Richelle J. F.
    GASTROENTEROLOGY NURSING, 2021, 44 (01) : 39 - 46
  • [43] Anterior Sphincteroplasty for Fecal Incontinence: Is the Outcome Compromised in Patients With Associated Pelvic Floor Injury?
    Oom, Daniella M. J.
    Steensma, Anneke B.
    Zimmerman, David D. E.
    Schouten, W. Rudolph
    DISEASES OF THE COLON & RECTUM, 2010, 53 (02) : 150 - 155
  • [44] Inflammatory Bowel Disease and Non-Relaxing Pelvic Floor Dysfunction
    Tremaine, William J.
    Raffals, Laura H.
    Bharucha, Adil E.
    Timmons, Lawrence J.
    Pemberton, John H.
    Camilleri, Michael
    GASTROENTEROLOGY, 2013, 144 (05) : S104 - S104
  • [45] The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease
    Abdelbary, Mohamed M. H.
    Hatting, Maximilian
    Bott, Alexandra
    Dahlhausen, Andrea
    Keller, Doris
    Trautwein, Christian
    Conrads, Georg
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [46] WHICH PATIENTS ARE MOST LIKELY TO BENEFIT FROM GUT-DIRECTED HYPNOTHERAPY FOR REFRACTORY IRRITABLE BOWEL SYNDROME?
    Devenney, Jade
    Hasan, Syed S.
    Morris, Julie
    Whorwell, Peter J.
    Vasant, Dipesh
    GUT, 2022, 71 : A35 - A35
  • [47] Gut directed hypnosis for patients with inflammatory bowel diseases (IBD)
    Greifenegg, M.
    Michalski, M.
    Dejaco, C.
    Moser, G.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2013, 82 : 39 - 40
  • [48] Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Gu, Phillip
    Kuenzig, M. Ellen
    Kaplan, Gilaad G.
    Pimentel, Mark
    Rezaie, Ali
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (06) : 1280 - 1290
  • [49] Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Gu, Phillip
    Kuenzig, Ellen
    Kaplan, Gilaad
    Pimentel, Mark
    Rezaie, Ali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S427 - S427
  • [50] BEHAVIORAL TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    SCHWARZ, SP
    BLANCHARD, EB
    BIOFEEDBACK AND SELF-REGULATION, 1989, 14 (02): : 166 - 167